Search

Background: The optimal right ventricular pacing site for patients requiring pacemaker implantation for permanent atrioventricular block is a matter of debate. Long-term right ventricular apical pacing has been associated with left ventricular ejection fraction impairment and heart failure. Right ventricular septal pacing has been proposed as an alternative., Aim: The aim of this randomized prospective multicentre trial was to compare left ventricular remodelling and outcomes between right ventricular apical and septal pacing after mid-term follow-up., Methods: Patients requiring pacemaker implantation for high-degree atrioventricular block were enrolled and randomized in a 1:1 fashion to receive a right ventricular apical or septal lead., Results: A total of 141 patients were included, 69 in the septal group and 72 in the apical group. Both groups exhibited similar left ventricular ejection fractions after 18 months of follow-up (septal 57.1±11.9% vs. apical 57.4±13.4%), and left ventricular ejection fraction variation was similar in the two groups at the end of follow-up (septal -1.5±13.2% vs. apical 0.3±13.3%). Additionally, left ventricular volume, quality of life and 6-minute walk distance were similar in the two groups. However, patients in the septal group were more likely to be asymptomatic, with a significantly lower concentration of N-terminal prohormone of brain natriuretic peptide. Lastly, lead position did not impact 18-month survival., Conclusion: Pacing from the right ventricular apex does not have any detrimental effect on left ventricular systolic function compared with septal pacing over an 18-month period., (Copyright © 2022. Published by Elsevier Masson SAS.)

Background: The recently recommended single lead-based criterion for the diagnosis of Brugada syndrome may lead to overdiagnosis of this disorder and overestimation of the risk of sudden cardiac death., Aim: To investigate the value of a single-lead diagnosis in patients with Brugada syndrome and a spontaneous type 1 electrocardiogram., Methods: Consecutive patients with Brugada syndrome were included in a multicentre prospective registry; only those with a spontaneous type 1 electrocardiogram were enrolled. Clinical and electrocardiogram data were reviewed by two physicians blinded to the patients' clinical and genetic status., Results: Among 1613 patients, 505 (31%) were enrolled (79% male; mean age 46±15 years). A spontaneous type 1 electrocardiogram pattern was found in one lead in 250 patients (group 1), in two leads in 227 patients (group 2) and in three leads in 27 patients (group 3). Groups were similar except for individuals in group 3, who presented more frequently a fragmented QRS complex, an early repolarization pattern and a prolonged T peak -T end interval. After a mean follow-up of 6.4±4.7 years, ventricular arrhythmia, sudden cardiac death or implantable cardiac defibrillator shock occurred in 46 (9%) patients, without differences between groups., Conclusion: The prognosis of Brugada syndrome with a spontaneous type 1 electrocardiogram pattern does not appear to be affected by the number of leads required for the diagnosis., (Copyright © 2019 Elsevier Masson SAS. All rights reserved.)

Background: Defibrillation testing (DT) is usually performed during implantable cardioverter defibrillator (ICD) implantation., Aims: We conducted a multicentre prospective study to determine the DT procedures used in everyday practice, to compare the characteristics of patients with or without DT, and to compare severe adverse events in these two populations during implantation and follow-up., Methods: The LEADER registry enrolled 904 patients included for primo-implantation of a single (n=261), dual (n=230) or triple (n=429) defibrillation system in 42 French centres., Results: Baseline characteristics of patients (62.0 ± 13.5 years; 88% men; primary indication 62%) who underwent ventricular fibrillation (VF) induction (VF induction group, n=810) and those who did not (untested group, n=94, representing 10.4% of the entire study population) revealed that the untested group were older (P<0.01), had a lower left ventricular ejection fraction, a wider QRS complex and a higher New York Heart Association class and were more often implanted for primary prevention (P<0.001 for all). The main reason given for not performing ICD testing was poor haemodynamic condition (59/94). At 1 year, the cumulative survival rate was 95% in tested patients and 85% in untested patients (P<0.001), mainly because of heart failure deaths. There was one sudden cardiac death in the VF induction group and none in the untested group (P=1.000)., Conclusions: In this study, more than 10% of ICD patients were implanted without VF induction. Untested patients appeared to be sicker than tested patients, with a more severe long-term outcome, but without any difference in mortality due to arrhythmic events., (Copyright © 2013 Elsevier Masson SAS. All rights reserved.)

Objective: To evaluate, on the basis of long-term outcome, the value of electrophysiologic exploration for determining the cause of syncope of unknown origin after clinical examination and standard laboratory tests., Methods: In 1985 and 1986, 109 consecutive patients with syncope of unknown origin underwent electrophysiologic exploration. The patients were divided into two groups. Baseline electrocardiogram was abnormal in 59 patients: cardiopathy (32%), ischemia (17%). In 44 of these patients, electrophysiologic exploration revealed major abnormalities requiring treatment (Group 1). No aetiology could be defined in 65 patients (Group 2). Patients were followed for 37 +/- 11 months. Three were lost to follow-up and 106 were retained for analysis., Results: Morbidity and mortality were 25% and 16% respectively at the end of follow-up. Two sudden deaths were recorded, both in Group 1. Total mortality was greater in Group 1 (10 vs 6) so electrophysiologic exploration had defined a population at lower risk of sudden death and overall mortality. Relapse of syncope was observed in 27 patients (25% and 26% in Groups 1 and 2 respectively) due to rhythm disorders in 8, vasodepression in 1 and unknown origin in 18., Conclusion: The rate of recurrent syncope suggests these patients should have a second work-up in order to diagnose initially false negatives. Relapse raises the problem of electrophysiologic abnormalities and multifactorial mechanisms causing syncope of unknown origin.

Velocity of the middle cerebral artery was recorded with transcranial pulsed doppler in 10 neurally-mediated syncopes elicited by 60 degrees head-up tilt test. Mean arterial blood pressure decreased by -36 +/- 16 percent (P < 0.0001) and heart rate by -6 +/- 27 percent (P < 0.05). Mean middle cerebral artery velocity decreased by -48 +/- 16 percent (P < 0.0001); Pourcelot's resistance index increased by 74 +/- 47 percent (P < 0.0001) and Gosling's pulsatility index by 218 +/- 111 percent (P < 0.0001). However, resistance normalized with mean arterial pressure showed no significant increase (+ 14 +/- 28 percent; NS). The decrease in diastolic velocity as well as mean arterial blood pressure and heart rate was significantly lower when loss of consciousness occurred. Contrary to those of other authors, our results do not support the hypothesis that syncopes result from a paradoxical cerebral vasoconstriction since no significant changes were observed in resistance normalized with mean arterial pressure. Thus, decrease in cerebral perfusion is likely to be the result of a decrease in cerebral perfusion pressure.